Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807691
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807691
Oncology Based Molecular Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Type, By Technology, By Region - Market Forecast, 2025-2034
PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The oncology-based molecular diagnostics market size is expected to reach USD 6.12 billion by 2034, according to a new study by Polaris Market Research. The report "Oncology Based Molecular Diagnostics Market Share, Size, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Type, By Technology, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Oncology-based molecular diagnostics are advanced tools that decode cancer-related genetic and molecular alterations to guide precise clinical decision-making. The oncology-based molecular diagnostics market is expanding due to the growing focus on precision oncology, where molecular insights are increasingly being used to tailor treatment strategies based on individual tumor profiles. This trend reflects a broader transformation in cancer care, moving from generalized therapies to targeted approaches that improve efficacy and minimize adverse effects. The growing demand for such personalized solutions is driving continuous innovation and integration of molecular diagnostics into standard oncology workflows.
The increasing adoption of noninvasive diagnostic techniques, such as liquid biopsy, which offer real-time monitoring and early detection without the need for surgical procedures, further contributes to the growth opportunities. These advancements are expanding the clinical utility of molecular diagnostics by enabling dynamic assessment of disease progression and treatment response. The development and utilization of such technologies are expected to remain at the forefront of the oncology diagnostics landscape as healthcare providers seek to enhance patient outcomes through minimally invasive and highly accurate diagnostics.
Oncology Based Molecular Diagnostics Market Report Highlights
In terms of product, the reagents segment led the market with 58.61% revenue share, as they are essential for various molecular diagnostic tests such as PCR, sequencing, and hybridization.
Based on technology, the sequencing segment is projected to grow the fastest due to its ability to deliver detailed, high-resolution cancer genomic insights.
North America dominated the oncology molecular diagnostics market with a 44.69% global share in 2024, supported by advanced healthcare infrastructure, a robust research ecosystem, and early adoption of innovative diagnostic technologies.
Asia Pacific market is expected to grow the fastest during the forecast period, fueled by supportive regulations, high diagnostic standards, and rising demand for personalized cancer care.
A few global key players in the oncology based molecular diagnostics market include Artivion, Inc.; Aroa Oncology Based Molecular Diagnostics; B. Braun SE; Baxter; BD; INTEGRA LIFESCIENCES; Johnson & Johnson Services, Inc.; Medtronic; Pfizer Inc.; Sanofi; and Stryker.
Polaris Market Research has segmented the oncology based molecular diagnostics market report on the basis of type, product, technology, and region:
By Type Outlook (Revenue, USD Billion, 2020-2034)
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Liver Cancer
Lung Cancer
Blood Cancer
Kidney Cancer
Others
By Product Outlook (Revenue, USD Billion, 2020-2034)
Instruments
Reagents
Others
By Technology Outlook (Revenue, USD Billion, 2020-2034)
PCR
In situ hybridization
INAAT
Chips and microarrays
Mass spectrometry
Sequencing
TMA
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Product Code: PM6200
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Oncology Based Molecular Diagnostics Market Insights
- 4.1. Oncology Based Molecular Diagnostics Market - Market Snapshot
- 4.2. Oncology Based Molecular Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Incidence and Prevalence of Cancer Globally
- 4.2.1.2. Rising Advancement in Molecular Oncology Tests Technology
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High R&D and operational costs
- 4.2.3. Public opinion and privacy legal precedents
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Oncology Based Molecular Diagnostics Market Trends
- 4.6. Value Chain Analysis
5. Global Oncology Based Molecular Diagnostics Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 5.3. Breast Cancer
- 5.3.1. Global Oncology Based Molecular Diagnostics Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
- 5.4. Prostate Cancer
- 5.4.1. Global Oncology Based Molecular Diagnostics Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
- 5.5. Colorectal Cancer
- 5.5.1. Global Oncology Based Molecular Diagnostics Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
- 5.6. Cervical Cancer
- 5.6.1. Global Oncology Based Molecular Diagnostics Market, by Cervical Cancer, by Region, 2020-2034 (USD Billion)
- 5.7. Liver Cancer
- 5.7.1. Global Oncology Based Molecular Diagnostics Market, by Liver Cancer, by Region, 2020-2034 (USD Billion)
- 5.8. Lung Cancer
- 5.8.1. Global Oncology Based Molecular Diagnostics Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
- 5.9. Blood Cancer
- 5.9.1. Global Oncology Based Molecular Diagnostics Market, by Blood Cancer, by Region, 2020-2034 (USD Billion)
- 5.10. Kidney Cancer
- 5.10.1. Global Oncology Based Molecular Diagnostics Market, by Kidney Cancer, by Region, 2020-2034 (USD Billion)
- 5.11. Others
- 5.11.1. Global Oncology Based Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
6. Global Oncology Based Molecular Diagnostics Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 6.3. Instruments
- 6.3.1. Global Oncology Based Molecular Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
- 6.4. Reagents
- 6.4.1. Global Oncology Based Molecular Diagnostics Market, by Reagents, by Region, 2020-2034 (USD Billion)
- 6.5. Others
- 6.5.1. Global Oncology Based Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
7. Global Oncology Based Molecular Diagnostics Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 7.3. PCR
- 7.3.1. Global Oncology Based Molecular Diagnostics Market, by PCR, by Region, 2020-2034 (USD Billion)
- 7.4. In situ hybridization
- 7.4.1. Global Oncology Based Molecular Diagnostics Market, by In situ hybridization, by Region, 2020-2034 (USD Billion)
- 7.5. INAAT
- 7.5.1. Global Oncology Based Molecular Diagnostics Market, by INAAT, by Region, 2020-2034 (USD Billion)
- 7.6. Chips and microarrays
- 7.6.1. Global Oncology Based Molecular Diagnostics Market, by Chips and microarrays, by Region, 2020-2034 (USD Billion)
- 7.7. Mass spectrometry
- 7.7.1. Global Oncology Based Molecular Diagnostics Market, by Mass spectrometry, by Region, 2020-2034 (USD Billion)
- 7.8. Sequencing
- 7.8.1. Global Oncology Based Molecular Diagnostics Market, by Sequencing, by Region, 2020-2034 (USD Billion)
- 7.9. TMA
- 7.9.1. Global Oncology Based Molecular Diagnostics Market, by TMA, by Region, 2020-2034 (USD Billion)
- 7.10. Others
- 7.10.1. Global Oncology Based Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
8. Global Oncology Based Molecular Diagnostics Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Oncology Based Molecular Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Oncology Based Molecular Diagnostics Market - North America
- 8.3.1. North America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.3.3. North America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.3.4. Oncology Based Molecular Diagnostics Market - US
- 8.3.4.1. US: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.3.4.2. US: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.3.4.3. US: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.3.5. Oncology Based Molecular Diagnostics Market - Canada
- 8.3.5.1. Canada: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.4. Oncology Based Molecular Diagnostics Market - Europe
- 8.4.1. Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.3. Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.4. Oncology Based Molecular Diagnostics Market - UK
- 8.4.4.1. UK: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.5. Oncology Based Molecular Diagnostics Market - France
- 8.4.5.1. France: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.5.3. France: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.6. Oncology Based Molecular Diagnostics Market - Germany
- 8.4.6.1. Germany: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.7. Oncology Based Molecular Diagnostics Market - Italy
- 8.4.7.1. Italy: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.8. Oncology Based Molecular Diagnostics Market - Spain
- 8.4.8.1. Spain: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.9. Oncology Based Molecular Diagnostics Market - Netherlands
- 8.4.9.1. Netherlands: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.10. Oncology Based Molecular Diagnostics Market - Russia
- 8.4.10.1. Russia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.11. Oncology Based Molecular Diagnostics Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.5. Oncology Based Molecular Diagnostics Market - Asia Pacific
- 8.5.1. Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.4. Oncology Based Molecular Diagnostics Market - China
- 8.5.4.1. China: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.4.3. China: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.5. Oncology Based Molecular Diagnostics Market - India
- 8.5.5.1. India: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.5.3. India: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.6. Oncology Based Molecular Diagnostics Market - Malaysia
- 8.5.6.1. Malaysia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.7. Oncology Based Molecular Diagnostics Market - Japan
- 8.5.7.1. Japan: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.8. Oncology Based Molecular Diagnostics Market - Indonesia
- 8.5.8.1. Indonesia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.9. Oncology Based Molecular Diagnostics Market - South Korea
- 8.5.9.1. South Korea: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.10. Oncology Based Molecular Diagnostics Market - Australia
- 8.5.10.1. Australia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.11. Oncology Based Molecular Diagnostics Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.6. Oncology Based Molecular Diagnostics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.4. Oncology Based Molecular Diagnostics Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.5. Oncology Based Molecular Diagnostics Market - UAE
- 8.6.5.1. UAE: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.6. Oncology Based Molecular Diagnostics Market - Israel
- 8.6.6.1. Israel: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.7. Oncology Based Molecular Diagnostics Market - South Africa
- 8.6.7.1. South Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.8. Oncology Based Molecular Diagnostics Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.7. Oncology Based Molecular Diagnostics Market - Latin America
- 8.7.1. Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.7.4. Oncology Based Molecular Diagnostics Market - Mexico
- 8.7.4.1. Mexico: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.7.5. Oncology Based Molecular Diagnostics Market - Brazil
- 8.7.5.1. Brazil: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.7.6. Oncology Based Molecular Diagnostics Market - Argentina
- 8.7.6.1. Argentina: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 8.7.7. Oncology Based Molecular Diagnostics Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bayer AG
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. BD
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Cepheid
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Agilent Technologies, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Danaher
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Hologic, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Qiagen
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. F. Hoffmann-La Roche Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Siemens
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Sysmex
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
Product Code: PM6200
List of Tables:
- Table 1 Global Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 2 Global Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 3 Global Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 4 North America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 5 North America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 6 North America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 7 US: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 8 US: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 9 US: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 10 Canada: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 11 Canada: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 12 Canada: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 13 Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 14 Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 15 Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 16 UK: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 17 UK: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 18 UK: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 19 France: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 20 France: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 21 France: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 22 Germany: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 23 Germany: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 24 Germany: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 25 Italy: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 26 Italy: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 27 Italy: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 28 Spain: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 29 Spain: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 30 Spain: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 31 Netherlands: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 32 Netherlands: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 33 Netherlands: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 34 Russia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 35 Russia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 36 Russia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 37 Rest of Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 38 Rest of Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 39 Rest of Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 40 Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 41 Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 42 Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 43 China: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 44 China: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 45 China: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 46 India: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 47 India: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 48 India: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 49 Malaysia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 50 Malaysia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 51 Malaysia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 52 Japan: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 53 Japan: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 54 Japan: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 55 Indonesia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 56 Indonesia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 57 Indonesia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 58 South Korea: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 59 South Korea: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 60 South Korea: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 61 Australia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 62 Australia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 63 Australia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 64 Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 65 Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 66 Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 67 Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 68 Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 69 Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 70 Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 71 Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 72 Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 73 UAE: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 74 UAE: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 75 UAE: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 76 Israel: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 77 Israel: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 78 Israel: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 79 South Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 80 South Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 81 South Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 82 Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 83 Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 84 Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 85 Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 86 Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 87 Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 88 Mexico: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 89 Mexico: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 90 Mexico: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 91 Brazil: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 92 Brazil: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 93 Brazil: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 94 Argentina: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 95 Argentina: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 96 Argentina: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- Table 97 Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
- Table 98 Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- Table 99 Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
List of Figures:
- Figure 1. Global Oncology Based Molecular Diagnostics Market, 2020-2034 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Price
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Type
- Figure 7. Global Oncology Based Molecular Diagnostics Market, by Type, 2024 & 2034 (USD Billion)
- Figure 8. Market by Product
- Figure 9. Global Oncology Based Molecular Diagnostics Market, by Product, 2024 & 2034 (USD Billion)
- Figure 10. Market by Technology
- Figure 11. Global Oncology Based Molecular Diagnostics Market, by Technology, 2024 & 2034 (USD Billion)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.